Press releases

/ Archive


Media Contact:
David E. Anderson
Global Vice President of Marketing
david.anderson@greenbiologics.com



Green Biologics Starts Construction in Little Falls, MN

Building a 100 percent Renewable, Bio-Based n-Butanol & Acetone Plant

Gahanna, Ohio and Abingdon, England (December 2, 2015)
– Green Biologics Ltd., a U.K. based industrial biotechnology and renewable chemicals company,is moving forward with the construction of its 100 percent renewable, bio-based n-butanol and acetone manufacturing facility in Little Falls, MN. The existing manufacturing site, formerly known as The Central MN Ethanol Cooperative (CMEC), was acquired by Green Biologics in December 2014 and re-named Central MN Renewables (CMR). Permitting was completed in late August and the construction began on September 1, 2015. Commercial production is scheduled to commence in 2016 ...

Read more

The American Chemistry Council Approves Membership for Green Biologics

Renewable speciality chemicals company furthers commitment to sustainability by joining industry-leading trade association

Gahanna, Ohio and Abingdon, England (November 9, 2015)
– Green Biologics Ltd., a U.K. based industrial biotechnology and renewable chemicals company was approved for membership to the American Chemistry Council (ACC) on November 5th. The American Chemistry Council represents the leading companies engaged in the business of chemistry, with its mission to deliver business value through exceptional advocacy using best-in-class member performance, political engagement, communications and scientific research. Additionally, ACC is committed to improved environmental, health and safety performance through the world-class Responsible Care® initiative, participation in which is a condition of ACC membership. Members range from large multinational companies such as Dow, DuPont, and BASF to small and medium size enterprises like Green Biologics...

Read more

ButaNext: Innovating to Create a More Effective Generation of Biofuels
Green Biologics Leads Coordination of European Consortium on Lignocellulosic Butanol

Gahanna, Ohio and Abingdon, Oxfordshire U.K. (June 15,2015) – New and improved processes and techniques, based on the cost-effective production of biobutanol, will produce a new generation of cheaper and more environmentally friendly biofuels.
Such is the aim of the new EU-funded ButaNexT project (Next Generation Biobutanol) which held a successful kick off meeting in Brussels on 21-22 May 2015. ...

Read more

Green Biologics Wins Award at Global Cleantech Forum Europe 2015

Collects Standout Fundraising Achievement of the Year Award by Cleantech Group

Gahanna, Ohio and Abingdon, England (April 28, 2015)
– Green Biologics Ltd., a U.K. based industrial biotechnology and renewable chemicals company was awarded the Standout Financial Achievement of the Year Award on April 28, 2015 in Florence, Italy by Cleantech Group, whose mission is to connect corporates to sustainable innovation through the i3 market intelligence platform, expert consulting services, and global events. Green Biologics was named to the Global Cleantech 100 list in 2009, 2011 and 2014.

Read more

Green Biologics Appoints Jim Hohman to its Board of Directors
Chemical Industry Executive to Play Key Non-Executive Role

Gahanna, Ohio and Abingdon, Oxfordshire U.K. (February 4, 2015) – Green Biologics (GBL) announced today the appointment of James J. Hohman to a non-executive director position on their board of directors. Hohman was formerly President of OMNOVA Solutions’ Performance Chemicals business unit and a corporate Senior Vice President of OMNOVA.
Prior to GenCorp/OMNOVA, Mr. Hohman held key general management, business and marketing management positions with BP Chemicals and B.F. Goodrich...

Read more

Green Biologics Secures $76 Million in Debt and Equity Financing
Proceeds position Company to Deliver 1st Commercial Plant in U.S.

Gahanna, Ohio and Abingdon, Oxfordshire U.K. (January 21, 2015) – Green Biologics (GBL) announced today the closing of an internal follow-on equity round of $42 million co-led by Swire Pacific Limited (HKEX: 00019/00087) and Sofinnova Partners. Existing investors Capricorn Venture Partners, Oxford Capital Partners, Morningside Technology Partners and ConvergInce Holdings, LLC also participated in the round. ...

Read more

Gahanna, Ohio and Abingdon UK (December 23, 2014) – Green Biologics Inc. today announced the successful closing of its acquisition of the assets of Central MN Ethanol Cooperative LLC (CMEC). Green Biologics intends to repurpose the operation, which includes a 21 million gallon per year ethanol plant, to produce renewable n-butanol and acetone, utilising its proprietary advanced fermentation process (AFP™) technology platform.

Read more

Green Biologics is Named # 6 in the 40 Hottest Smaller Companies in the Advanced Bio-Economy by Biofuels Digest

Abingdon, Oxfordshire U.K. (November 10, 2014)
– Green Biologics Ltd. (GBL), a UK based industrial biotechnology and renewable chemicals company, was named on November 10, 2014 to the 40 Hottest Smaller Companies in the Advanced Bio-Economy list (#6) and to the 30 Hottest Companies in Bio-based Chemicals and Materials (#28). The Rankings are compiled by Biofuels Digest, and were awarded at a gala reception held at the Fairmont San Francisco, CA. This marks the first time GBL was named to either the Hot 30 or the Hot 40 list.

Read more

Green Biologics is Named in the 2014 Global Cleantech 100

List Recognises the Top Private Companies in Clean Technology

Abingdon, England (October 6, 2014)
Green Biologics Ltd., an industrial biotechnology and renewable chemicals company based in Milton Park, today announced it was named in the prestigious 2014 Global Cleantech 100, produced by Cleantech Group, whose mission is to connect corporates to sustainable innovation through the i3 market intelligence platform, expert consulting services, and global events.

Read more

Green Biologics Receives $500,000 Grant to Advance Renewable Chemical Production in Minnesota

Abingdon, England (May 19, 2014)
– Central Minnesota Renewables LLC (CMR), Green Biologics’ subsidiary formed to launch the company into commercial production of renewable n-butanol, has received a $500,000 grant from the Minnesota Department of Agriculture (MDA) to support the repurpose of an ethanol facility in Little Falls, MN. CMR was one of five projects selected to receive NextGen Energy grants by the MDA. The grants fall under the Agricultural Growth, Research and Innovation (AGRI) program to help creative and emerging agricultural projects acquire funding.

Read more

Oxford, England (December 2nd, 2013) – Green Biologics Ltd. (“GBL”), a technology developer and emerging bio-based C4 chemicals producer, focused on renewable n-butanol, based near Oxford, UK announced today the closing of a £15.4 million (~ $25 million) Series B round led by Sofinnova Partners with strategic participation by Swire Pacific Limited. Follow on investments were also made by funds advised by Capricorn Venture Partners and Oxford Capital Partners and by Morningside Ventures and ConvergInce Holdings LLC.

Read more

GREEN BIOLOGICS, INC. AND CENTRAL MN ETHANOL CO-OP SIGN EXCLUSIVE LETTER OF INTENT

Parties agree to exclusively negotiate the final terms for Green Biologics, Inc. to acquire the assets of Central MN Ethanol Co-op.

Abingdon, England and Gahanna, Ohio (September 11, 2013)
– Green Biologics, Inc. (“GBI”), a technology developer and emerging bio-based chemicals producer based in Gahanna, Ohio, and Central MN Ethanol Co-op (“CMEC”), an ethanol producer in Little Falls, MN, today announced that Green Biologics, Inc. has entered into an exclusive letter of intent to acquire substantially all of CMEC’s assets.

Read more

Green Biologics Signs Deal for Iowa Demonstration Plant with Easy Energy Systems

Abingdon, Oxfordshire U.K. (July 2, 2013)
– Green Biologics Limited (Green Biologics), a UK-based industrial biotechnology company with pilot scale facilities and offices in Columbus, Ohio, has announced a collaboration and planned investment in facilities with Easy Energy Systems Inc (Easy Energy). The collaboration will result in the modification of Easy Energy’s ethanol demonstration plant in Emmetsburg, Iowa to produce renewable n-butanol and acetone.

Read more

Green Biologics is Awarded Grant Funding to Advance the Industrial Application of Synthetic Biology

ABINGDON, OXFORDSHIRE, UNITED KINGDOM – 7th March 2013:
Green Biologics Ltd. (GBL), a leading industrial biotechnology company focused on the production of biobutanol and other C4 chemicals from a range of sustainable and renewable feedstocks, today announced it has been awarded grant funding from the Technology Strategy Board (TSB), the UK’s innovation agency, to engineer a novel bacterial host for biobutanol production.

Read more

Green Biologics Announces Knowledge Transfer Partnership with the University of Nottingham

Abingdon, Oxfordshire U.K. (March 9, 2012):
- Green Biologics Limited (GBL), a UK-based industrial biotechnology company announces a Knowledge Transfer Partnership between GBL and an academic group in the BBSRC Sustainable Bioenergy Centre at the University of Nottingham, led by Professor Nigel Minton. This two year project is funded by the Technology Strategy Board and Biotechnology and Biological Sciences Research Council (BBSRC), and supports a full time Research Associate at Green Biologics Ltd.

Read more

Green Biologics Announces Merger with butylfuel™

Abingdon, Oxfordshire U.K. (January 20, 2012):
- Green Biologics Limited (GBL), a UK-based industrial biotechnology company announces the merger between GBL and butylfuel™ Inc., a US-based renewable chemicals and biofuels company. The new company will operate under the Green Biologics name and continue to be head-quartered in Abingdon, UK with a strong operational presence and commercial focus in the US contributed by butylfuel™ Inc., which will become Green Biologics, Inc. The effective date for the all equity merger is January 1, 2012.

Read more

The Global Cleantech 100 list is unique in the sector because it highlights the promise of private clean technology companies from all around the world, focusing on those companies which are most likely to make the most significant market impact over the next 5-10 years. 

"The third Global Cleantech 100 exemplifies the best in cleantech innovation across the world." said Richard Youngman, Managing Director, Europe & Asia, Cleantech Group and the founder of the Global Cleantech 100. "This list is based on the collective wisdom and experience of the world's cleantech leaders and this year it truly reflects not only the most interesting companies, but also the mainstreaming of this dynamic industry."

Read more

GBL and Songyuan Laihe Chemical Company (Laihe) enter into a Technology Collaboration Agreement

GBL and Songyuan Laihe Chemical Company (Laihe) enter into a Technology Collaboration Agreement GBL and Laihe Chemical Co. a company focused on producing bio-fuels and bio-chemicals from non-food bio-mass resources have entered into a collaborative development and licensing agreement  in China . Under the terms of the agreement GBL and Laihe will collaborate to improve the economics of Laihe's biobutanol plant by optimising GBLs fermentation technology using sugars derived using Laihe cellulosic pre-treatment process. It is anticipated that the optimised process will be in pilot trials before the end of 2011 and will be in full commercial production in 2012 

Read more

Green Biologics nominated as 2011 New Energy Pioneer Green Biologics has been nominated as a 2011 New Energy Pioneer in the Bloomberg New Energy Finance Pioneer program along with nine other companies at the fourth annual Bloomberg New Energy Finance Summit in New York.

In its second year, the Bloomberg New Energy Finance Pioneers program identifies companies from across the world that are making significant gains in the field of clean technology and innovation. A panel of industry experts, led by Bloomberg New Energy Finance technology specialists, chose the honorees by assessing them against three criteria: potential scale, innovation and momentum.     Each of the New Energy Pioneers has worked to develop unique technologies and has demonstrated the potential for these technologies to be competitive in the marketplace and implemented on a large scale. 

Read more

GBL named in 2010 Global Cleantech 100 list and listed in Top 10 most promising Cleantech companies in Europe and Israel

 GBL named in 2010 Global Cleantech 100 list and listed in Top 10 most promising Cleantech companies in Europe and IsraelGBL have been named in the prestigious 2010 Global Cleantech 100 and are also listed in the Top 10 of the most promising Cleantech companies in Europe and Israel, produced by the Cleantech Group, providers of leading global market research, events and advisory services for the cleantech industry. The list is produced as part of the Global Cleantech 100 program, run in collaboration with the Guardian News and Media and sponsored by Autodesk.

The Global Cleantech 100 highlights the most promising private clean technology companies from all around the world, those companies which are the most likely to make the most significant market impact over the next 5-10 years, in the eyes of the world's cleantech experts.

Read more

Green Biologics are nominated in 'Top 30 Most Transformative Technologies of 2010' poll

Green Biologics are nominated in 'Top 30 Most Transformative Technologies of 2010' poll In Florida, Biofuels Digest announced the winners of its '30 Most Transformative Technologies of 2010' poll. The publication's readers submitted more than 48,000 votes from 3,500 ballots during the three-week voting process. The readers chose between transformative bioenergy technologies at more than 250 companies, universities and national laboratories, including 100 organizations that received write-in votes. Green Biologics was the only non-US biobutanol company to be named in the top 30. The following link provides more details:
http://www.chem.info/Products/2010/06/Alternative-Energy-30-Most-Transformative-Technologies-of-2010

Read more

GBL raises £4.9 million to deliver bio-butanol for biochemicals and biofuels GBL is pleased to announce the completion of an investment round of £4.9 million to roll out its technology and commercialisation plans.

The round was led by Capricorn Venture Partners, a new investor in GBL through its Capricorn Cleantech Fund, and included participation by all GBL's existing institutional investors - Morningside Ventures, Carbon Trust Investment Limited and Oxford Capital Partners - as well as by management and founder investors.

Claude Stoufs, Senior Investment Manager at Capricorn Venture Partners, and David Brister, Operating Partner at Oxford Capital Partners, join the Board of GBL as part of this transaction.

Read more